A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers

A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers

Background: The combination of paclitaxel and cetuximab (PaCe) has led to an encouraging response rate in Phase 2 setting with limited toxicity. The aim of our study was to assess the efficacy of this regimen in our setting in platinum sensitive and nonsensitive patients. Methods: This was a retrosp...

Full description

Bibliographic Details
Main Authors: Vanita Noronha, Vijay M Patil, Amit Joshi, Atanu Bhattacharjee, Davinder Paul, Sachin Dhumal, Shashikant Juvekar, Supreeta Arya, Kumar Prabhash
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2017-01-01
Series:South Asian Journal of Cancer
Subjects:
Head and neck cancer
metastatic
oral cancer
palliative chemotherapy
recurrent
weekly paclitaxel
Online Access:http://journal.sajc.org/article.asp?issn=2278-330X;year=2017;volume=6;issue=1;spage=11;epage=14;aulast=Noronha

Internet

http://journal.sajc.org/article.asp?issn=2278-330X;year=2017;volume=6;issue=1;spage=11;epage=14;aulast=Noronha

Similar Items